NRB has a leadership position in needle roller bearings, conventional cylindrical roller bearings, and also a new generation of lightweight drawn cup bearings. It also manufactures planetary shafts, crank pins, And kingpins. PRICE TO BOOK VALUE - 2.95 P/E = 21 Debt to Equity - 0.51 Chart setup looks good, closure above 185 on DCB , will give targets of 223 , 240
Looking bullish !! Closed Above 10 , 20 , 50 , 100 , 200 EMA RSI>75 Break out 52 week high will bring 335 , 415 Targets with of SL 265
The Company provides healthcare services across secondary and tertiary care specialities, focusing on oncology, neurosciences, cardiac sciences, orthopaedics, renal sciences, liver and biliary sciences and minimal access metabolic and bariatric surgery (“MAMBS”) at the Network Healthcare Facilities. Closing above 449 wil bring 500 , 522 Trading above 10 , 20 ,...
The company has a diversified product portfolio with a basket of over 25 different products. These products are categorised under 3 main categories i.e. Amines, Amine derivatives and Specialty & Other chemicals. Return on Equity 10 Years: 26% 5 Years: 27% 3 Years: 29% Last Year: 34% Compounded Profit Growth 10 Years: 27% 5 Years: 36% 3 Years: 47% TTM: ...
TajGVK Hotels & Resorts Limited, incorporated in 1995, is a joint venture between the Hyderabad based GVK Group and Indian Hotels Company Limited (IHCL) Stock is trading at 3.34 times its book value Looking Bullish in chart Above 10,20,50,100,200 Day Moving average Breakout above 202 will bring target as mentioned in the chart , with SL of 182
Laxmi Organic Industries Limited was established in 1989 and is in the business of specialty chemicals. The Company primarily manufactures Ethyl Acetate, Acetic Acid and Diketene Derivative Products (DDP) Company has delivered good profit growth of 29.0% CAGR over last 5 years ; Price to book value 6.88 ; Debt to equity ratio 0.11 Looking good in charts (...
IEX is the first and largest energy exchange in India providing a nationwide, automated trading platform for physical delivery of electricity. Book Value 7.7 Current P/E : 41.9 ; Median P/E : 35 Trading below 10 , 21 , 63 , 100 , 200 EMA in daily chart Below 50 % in Fibonacci Retracement , Trying to to take support @ 0.618 Neutral - HOLD
40 years ago, Cipla started its fight against heart disease with innovative and high-class drugs. Over the years, cipla have been developing several products that help treat various diseases like MI, angina, heart failure, hypertension, arrhythmia, lipid abnormalities and diabetes, and obesity. Its API pipeline consists of 75+ complex developments in the therapy...